ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Bruker BioSciences, a life sciences materials and tools company, plans to acquire molecular spectroscopy firm Bruker Optics for $135 million in BBS stock and cash. Five members of the Laukien family who own Bruker Optics will share in the payout. The family members also own 58% of BBS. The combined firm, says BBS, will be a leading provider of instrumentation and molecular analysis solutions for a number of areas, including pharmaceutical, biotechnology, small-molecule, and metabolomics research.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter